Literature DB >> 25878565

Current Diagnosis and Management of Erectile Dysfunction.

Alexander W Pastuszak1.   

Abstract

Erectile dysfunction (ED) affects a growing number of men in the USA and abroad, with significant impacts on sexual function and overall quality of life. The risk factors for ED are numerous and include a strong link to cardiovascular disease, such that men with ED should be screened for cardiovascular disease. The evaluation of men presenting with ED includes a comprehensive history and physical exam to aid in the identification of comorbidities as well as laboratory testing to evaluate hormone and lipid levels and sugar metabolism. Adjunct studies are also available, though their utility is often limited to specific subtypes of ED. Once the etiology of ED is established, treatment can be initiated using appropriate medical therapies, including phosphodiesterase type 5 (PDE5) inhibitors, and transurethral or intracavernosal therapies, with surgical intervention via revascularization or penile prosthesis placement in men demonstrating a lack of response to medical therapy. In all cases of ED, a psychogenic component is present and referral for psychological intervention with or without medical therapy should be considered.

Entities:  

Keywords:  Acupuncture; Benign prostatic hypertrophy; Coronary artery disease; Erectile dysfunction; Hypogonadism; Intracavernosal injection; Intraurethral suppository; Lower urinary tract symptoms; Metabolic syndrome; PDE5 inhibitor; Penile prosthesis; Penile revascularization

Year:  2014        PMID: 25878565      PMCID: PMC4394737          DOI: 10.1007/s11930-014-0023-9

Source DB:  PubMed          Journal:  Curr Sex Health Rep        ISSN: 1548-3584


  129 in total

Review 1.  A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia.

Authors:  Mauro Gacci; Giovanni Corona; Matteo Salvi; Linda Vignozzi; Kevin T McVary; Steven A Kaplan; Claus G Roehrborn; Sergio Serni; Vincenzo Mirone; Marco Carini; Mario Maggi
Journal:  Eur Urol       Date:  2012-02-25       Impact factor: 20.096

2.  Acupuncture in the treatment of psychogenic erectile dysfunction: first results of a prospective randomized placebo-controlled study.

Authors:  P F Engelhardt; L K Daha; T Zils; R Simak; K König; H Pflüger
Journal:  Int J Impot Res       Date:  2003-10       Impact factor: 2.896

3.  Increased corpus cavernosum smooth muscle tone associated with partial bladder outlet obstruction is mediated via Rho-kinase.

Authors:  Shaohua Chang; Joseph A Hypolite; Stephen A Zderic; Alan J Wein; Samuel Chacko; Michael E Disanto
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-06-16       Impact factor: 3.619

Review 4.  Phosphodiesterase type 5 inhibitors' extended duration of response as a variable in the treatment of erectile dysfunction.

Authors:  M E Dunn; S E Althof; M A Perelman
Journal:  Int J Impot Res       Date:  2006-06-01       Impact factor: 2.896

Review 5.  Obesity, the metabolic syndrome, and sexual dysfunction.

Authors:  K Esposito; D Giugliano
Journal:  Int J Impot Res       Date:  2005 Sep-Oct       Impact factor: 2.896

6.  Prevalence of sexual activity and associated factors in men aged 75 to 95 years: a cohort study.

Authors:  Zoë Hyde; Leon Flicker; Graeme J Hankey; Osvaldo P Almeida; Kieran A McCaul; S A Paul Chubb; Bu B Yeap
Journal:  Ann Intern Med       Date:  2010-12-07       Impact factor: 25.391

7.  Sexual dysfunction in the United States: prevalence and predictors.

Authors:  E O Laumann; A Paik; R C Rosen
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272

8.  Diagnostic steps in the evaluation of patients with erectile dysfunction.

Authors:  Dimitrios Hatzichristou; Konstantinos Hatzimouratidis; Michael Bekas; Apostolos Apostolidis; Vasilios Tzortzis; Konstantinos Yannakoyorgos
Journal:  J Urol       Date:  2002-08       Impact factor: 7.450

9.  Increased incidence of depressive symptoms in men with erectile dysfunction.

Authors:  R Shabsigh; L T Klein; S Seidman; S A Kaplan; B J Lehrhoff; J S Ritter
Journal:  Urology       Date:  1998-11       Impact factor: 2.649

10.  Lower urinary tract symptoms are associated with depressive symptoms in white, black and Hispanic men in the United States.

Authors:  Edward O Laumann; Jeong-han Kang; Dale B Glasser; Raymond C Rosen; Culley C Carson
Journal:  J Urol       Date:  2008-05-21       Impact factor: 7.450

View more
  18 in total

1.  PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT.

Authors:  Aylin N Bilgutay; Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2015-06-01

2.  Poor Sleep Quality Predicts Hypogonadal Symptoms and Sexual Dysfunction in Male Nonstandard Shift Workers.

Authors:  Alexander W Pastuszak; Young M Moon; Jason Scovell; Justin Badal; Dolores J Lamb; Richard E Link; Larry I Lipshultz
Journal:  Urology       Date:  2016-12-14       Impact factor: 2.649

3.  Tofacitinib monotherapy and erectile dysfunction in rheumatoid arthritis: a pilot observational study.

Authors:  Yusuf Karabulut; Halise Hande Gezer; Selin Esen; İrfan Esen; Ali Rıza Türkoğlu
Journal:  Rheumatol Int       Date:  2022-04-25       Impact factor: 3.580

4.  Risk factors and the prognosis of sexual dysfunction in male patients with pituitary adenomas: a multivariate analysis.

Authors:  Wen-Jian-Long Zhou; Shun-Chang Ma; Min Zhao; Chang Liu; Xiu-Dong Guan; Zhao-Shi Bao; Gui-Jun Jia; Wang Jia
Journal:  Asian J Androl       Date:  2018 Jan-Feb       Impact factor: 3.285

5.  Demographics and sexual characteristics of sex-enhancing medication users: Study of a web-based cross-sectional sample of sexually active men.

Authors:  Abul-Fotouh Ahmed; Saad Alshahrani; Anthony Morgan; Ahmed H Gabr; Mohamed Abdel-Razik; Abdallah Daoud
Journal:  Arab J Urol       Date:  2017-11-06

6.  Prevalence and determinants of erectile dysfunction among diabetic patients attending in hospitals of central and northwestern zone of Tigray, northern Ethiopia: a cross-sectional study.

Authors:  Awole Seid; Hadgu Gerensea; Shambel Tarko; Yosef Zenebe; Rahel Mezemir
Journal:  BMC Endocr Disord       Date:  2017-03-15       Impact factor: 2.763

Review 7.  Erectile dysfunction, metabolic syndrome, and cardiovascular risks: facts and controversies.

Authors:  Edward Sanchez; Alexander W Pastuszak; Mohit Khera
Journal:  Transl Androl Urol       Date:  2017-02

Review 8.  Revisiting the Regenerative Therapeutic Advances Towards Erectile Dysfunction.

Authors:  Ming-Che Liu; Meng-Lin Chang; Ya-Chun Wang; Wei-Hung Chen; Chien-Chih Wu; Shauh-Der Yeh
Journal:  Cells       Date:  2020-05-19       Impact factor: 6.600

9.  Hip Fracture in People with Erectile Dysfunction: A Nationwide Population-Based Cohort Study.

Authors:  Chieh-Hsin Wu; Yi-Ching Tung; Tzu-Kang Lin; Chee-Yin Chai; Yu-Feng Su; Tai-Hsin Tsai; Cheng-Yu Tsai; Ying-Yi Lu; Chih-Lung Lin
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

10.  Deterioration of heart rate recovery index in patients with erectile dysfunction.

Authors:  Şeref Ulucan; Zeynettin Kaya; Ahmet Keser; Hüseyin Katlandur; Mustafa Karanfil; İsmail Ateş
Journal:  Anatol J Cardiol       Date:  2015-07-20       Impact factor: 1.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.